Menú Principal

!"#$#% &
'()*"+(,#%-+*-.($/"($#0"-1(2#.(-$%"3,(-'45!67
89-:

a a a

Calendario de vacunación
masiva contra COVID-19

>CALENDARIODEVACUNACIÓNCOVID-19 #YOME
VACUNACIÓNESCOLAR VACUNO
Desdeel27deseptiembre
Estecalendariopodríaestarsujetoacambios.

Semana27septiembre Semana04octubre Semana11octubre Semana18octubre

Vacunaciónescolarprimeradosis
niñasyniñosentre6y11años

#SigamosCuidándonos
Elcalendariodeprimerasdosisvatanrápidocomolopermitela
recepcióndevacunasennuestropaís.Respetarelcalendariode Ma@MeVacuno
vacunacionesmuyimportanteparaeléxitodeestacampaña.

¡DOSISDEREFUERZODESDE55AÑOS
DEL18AL22DEOCTUBRE
NARINO
Lunes18 Martes19 Miércoles20 Jueves21 Viernes22

Personasvacunadasconesquemacompleto
GRUPO1

hastael13DEJUNIO
(Esquemascompletos:Cansino,Janssen,Pfizer,Astrazeneca,
Generium,Moderna,Sinovac,Sinopharm)!

"Incluyepersonasvacunasenestudiosclínicosyconvalidacióndevacunasenelextranjero.
Personasinmunocomprometidasdesdelos12años*
GRUPO

Trasplantedeórganosólido,precursoreshematopoyéticos,cáncerentratamiento,enfermedades
autoinmunesentratamientosbiológicos/pequeñasmoléculas,dializados(hemooperitoneo).**
*Quehayanrecibidoesquemacompletohastael10deagosto.**Lospacientesdebenpresentarrecetaocertificadoqueacreditesucondicióndesalud.

0)@MeVacuno

'(50&,*.#6(7$8.(#.*79%7:*.3(*)7.0($&*
;<='>?@A

Busca en el sitio

EN VIVO - Resultado…

LIVE | Outcome of t…

#SigamosCuidándo…

Síguenos

!"#$$%& !"#"$%&'()*&+#&",-./0&"$

!"#$$%& )1"#"$%.&"'$02-3

!"#$$%& 4-5$.6&.%0&"0()/*0708

!"#$$%& 4-5$.6&.%0&"'()925.&%'*'-:#06

'()$*+&*, !"#"$%.&"'402-3

-*.%/001 !"#"$%.&"'(3.(402-3(;<"2.

203!3/% !"#"$%.&"'402-3;<"2.

-4#.1& !"#$02

Instituciones Relacionadas

'*"3,()-+*-PQ(23*$#1#*"3%-+*)-?#23*1(
R($#%"()-+*-?*,.#$#%2-+*-?()/+
F'SRPTP?BJ
U%"+%-R($#%"()-+*-?()/+-FU4RP?PJ
!"23#3/3%-+*-?()/+-VWQ)#$(-F!?VJ
?/X*,#"3*"+*"$#(-+*-?()/+

Transparencia

Y*2%)/$#0"-SZ*"3(-R[-H\K-]/*-(X,/*Q(
U%,1/)(,#%2-X(,(-Y*2W1*"*2-S23(+^23#$%2
;*"2/()*2
Y*2%)/$#0"-SZ*"3(-R[-8L<I-*23(Q)*$*
X,%@,(1(2-_-Q*$(2-+*-X*,D*$$#%"(1#*"3%
%-*2X*$#()#`($#0"-+*-A(23(-=-(a%2-+*
+/,($#0"
R%,1(3#.(2-+*2X*"()#`($#0"-(-)(
#"3*,,/X$#0"-.%)/"3(,#(-+*)-*1Q(,(`%-*"
O-'(/2()*2
Y*2%)/$#0"-SZ*"3(-R[-8K=I-(X,/*Q(
;("/()-+*-S@,*2%2-M%2X#3()(,#%2
S)*$$#0"-'%"2*b%-'%"2/)3#.%-cS?
V,%$*+#1#*"3%-+*-Y*$)/3(1#*"3%-_
?*)*$$#0"-(-$(,@%2-(-$%"3,(3(-*"-*)
;#"#23*,#%-+*-?()/+
V)("-+*-c*23#0"-P1Q#*"3()d-V,%_*$3%-+*
PX%_%-()-?*$3%,-?()/+
V,%3%$%)%-P/Z#)#%-SZ3,(%,+#"(,#%
Y*2%)/$#0"-]/*-(X,/*Q(-V)("-+*-R($#%"()
+*-S,,(+#$($#0"-+*-V%)#%1*)#3#2
V/Q)#$($#%"*2-#"23#3/$#%"()*2-2*@/"-N*_
+*-V,*2/X/*23%
Y*2%)/$#0"-Re-I88-6*2#@"(-?/b*3%2
V(2#.%2-N*_-ILdKOL-]/*-,*@/)(-*)-)%QQ_
V(@%-V,%.**+%,*2
!"#$#%
'%"2/)3(2-XWQ)#$(2

Campañas

Y%1X*8'#@(,,%-IL89
M("3(-IL89
!"f/*"`(-IL89
!".#*,"%-IL89
6%"($#0"-+*-g,@("%2
V,#1(.*,(75*,("%-IL8\
5!M-IL8\
c/^(-?()/+-;*"3()-V*,2%"(2-;(_%,*2
c/^(-?()/+-;*"3()-S23/+#("3*2-S+d
?/X*,#%,
5*,("%-IL897ILIL
P3*"$#%"*2-+*-h,@*"$#(
'#,$/)(,-5(X%,#`(+%,*2
c/^(-?()/+-;*"3()
S)-'A#)*-]/*-]/*,*1%2
S2-V%2#3#.%-?(Q*,
P@*"+(-?%$#()
5($W"(3*-PA%,(-'%"3,(-)(-!"f/*"`(
V,#1(.*,(-.*,("%-ILIL7ILI8
5($/"($#0"-?(,(1X#0"-ILIL
'(1X(a(-+*-#".#*,"%-ILIL
!"f/*"`(-ILIL

Especiales

4,#*"3($#%"*2-X(,(-)(-X)("#i$($#0"-_
X,%@,(1($#0"-+*-)(-,*+
4D*,3(-+*-?()/+-X(,(-V*,2%"(2-;(_%,*2
4,#*"3($#%"*2-3C$"#$(2-X(,(-($3/()#`(,-%
*)(Q%,(,-X,%3%$%)%-+*-3,(3%-_-,*@#23,%
X(,(-X*,2%"(2-3,("2
R%,1(-BC$"#$(-+*-B*b#+%2
R%,1(-BC$"#$(-2%Q,*-*23*,#)#`($#0"-_
+*2#"D*$$#0"
V%)^3#$(-+*-?()/+-+*-;#@,("3*2
!"3*,"($#%"()*2
!"D%,1($#0"-2%Q,*-U#*Q,*-j
V)("-R($#%"()-$%"3,(-)(-Y*2#23*"$#(-(-)%2
P"3#1#$,%Q#("%2
4,#*"3($#%"*2-BC$"#$(2-V(,(-*)-6#2*a%-+*
P"3*X,%_*$3%-+*-M%2X#3()*2-'%1X)*b%2
V)("-R($#%"()-+*-6*1*"$#(-IL8K
T#Q)#%3*$(-'%$A,("*-V)/2
c/^(2-')^"#$(2-R%-cS?
?#23*1(-+*-'*,3#i$($#0"-+*
S2X*$#()#+(+*2-+*-)%2-V,*23(+%,*2
!"+#.#+/()*2-+*-?()/+
Y*2/)3(+%2-S"$/*23(-'P?SR-IL8K-?*$3%,
?()/+
N*_-?PRRP
5($/"($#0"-(-.#(b*,%2
B/-U(,1($#(
S"$/*23(-R($#%"()-+*-?()/+-IL8H7IL8K
6%$/1*"3%2-B,(2X(2%-+*-c%Q#*,"%
'%1#2#0"-;C+#$(-P2*2%,(-X%,-N#23(2-+*
S2X*,(
V,%@,(1(-R($#%"()-+*-P)#1*"3($#0"
'%1X)*1*"3(,#(
'/#+(+%-+*-?()/+-T/$()
;%+*)%-+*-c*23#0"-V(,(-*)-U/"$#%(1#*"3%
+*-)(-Y*+-4"$%)0@#$(-+*-'A#)*
!"D%,1*-U#"()-ShRP'4;
B*,$*,(-S3(X(-N*_-+*-P)#1*"3%2
;%+*)%-+*-@*23#0"-+*-)(-,*+-"*/,%)0@#$(
*"-)(-(3*"$#0"-+*-)(2-X*,2%"(2-$%"
(3(]/*-$*,*Q,%-.(2$/)(,-FP'5J>
;(,$%-%X*,(3#.%-+*-)(-S23,(3*@#(-+*
$/#+(+%-#"3*@,()-$*"3,(+%-*"-)(2
X*,2%"(2-*"-$%"3*Z3%-+*-1/)3#1%,Q#)#+(+
6*$,*3%-SZ*"3%-ReHH-+*-ILI8

;($-!.*,-<=8>-?("3#(@%>-'A#)*-7-B*)CD%"%E-FG<H-IJ-I
<K=L-8LL

?*@/,#+(+-+*-)(-#"D%,1($#0" MB;N< '??-O

''